NDC properties for "ceftaroline fosamil 600 MG Injection" (RxCUI 1040014)
About this data
The tables show NDC propoerties for ceftaroline fosamil 600 MG Injection with the RxCUI 1040014
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for ceftaroline fosamil 600 MG Injection (RxCUI 1040014)
| ANDA | ANDA208075 |
|---|---|
| MMSL_CODE | CD26599 |
| RxCUI | 1040014 |
| SNOMEDCT | 1236785003 |
| SPL_SET_ID | 3cee3c08-ed60-06c5-ac49-103b7ad2ef5f |
| VUID | 4030286 |
| Prescribable Synonym | ceftaroline fosamil 600 MG Injection |
| RXNAV_STR | ceftaroline fosamil 600 MG Injection |
| RxNorm Name | ceftaroline fosamil 600 MG Injection |
| Related queries | Interactions (for RxCUI 1040014) |
NDC Properties
NDC Item 60505612500
| NDC 9 | 60505-6125 |
|---|---|
| NDC 10 | 60505-6125-0 |
| NDC Item | 60505612500 |
| Packaging | 20 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA208075 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2026-02-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 60505-6125 |
NDC Item 60505612501
| NDC 9 | 60505-6125 |
|---|---|
| NDC 10 | 60505-6125-1 |
| NDC Item | 60505612501 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (60505-6125-1) / 20 mL in 1 VIAL, SINGLE-DOSE (60505-6125-0) |
| ANDA | ANDA208075 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2026-02-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 60505-6125 |
NDC Item 60505612500
| NDC 9 | 60505-6125 |
|---|---|
| NDC 10 | 60505-6125-0 |
| NDC Item | 60505612500 |
| Packaging | 20 mL in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA208075 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2026-02-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 60505-6125 |
NDC Item 60505612501
| NDC 9 | 60505-6125 |
|---|---|
| NDC 10 | 60505-6125-1 |
| NDC Item | 60505612501 |
| Packaging | 10 VIAL, SINGLE-DOSE in 1 CARTON (60505-6125-1) / 20 mL in 1 VIAL, SINGLE-DOSE (60505-6125-0) |
| ANDA | ANDA208075 |
| Labeler | Apotex Corp. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2026-02-12 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 60505-6125 |